Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CNC NYSE:NXQ NASDAQ:TST NYSEARCA:XAR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCNCCentene$25.92-0.6%$43.39$25.11▼$80.59$12.73B0.422.87 million shs17.53 million shsNXQNuveen Select Tax-Free Income Portfolio 2$15.04$15.27$14.95▼$17.18$266.42M0.1425,365 shs38,459 shsTSTTheStreet$6.44$6.44$5.48▼$25.00$34.39M0.1730,021 shs508,322 shsXARSPDR S&P Aerospace & Defense ETF$214.28-1.0%$205.91$137.09▼$224.17$3.79B1.09145,495 shs314,633 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCNCCentene0.00%-8.60%-22.10%-56.65%-66.81%NXQNuveen Select Tax-Free Income Portfolio 20.00%0.00%0.00%0.00%0.00%TSTTheStreet0.00%0.00%0.00%0.00%0.00%XARSPDR S&P Aerospace & Defense ETF0.00%-2.81%+2.56%+21.25%+49.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCNCCentene4.929 of 5 stars4.13.00.03.73.03.33.1NXQNuveen Select Tax-Free Income Portfolio 2N/AN/AN/AN/AN/AN/AN/AN/ATSTTheStreetN/AN/AN/AN/AN/AN/AN/AN/AXARSPDR S&P Aerospace & Defense ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCNCCentene 2.12Hold$42.5364.09% UpsideNXQNuveen Select Tax-Free Income Portfolio 2 0.00N/AN/AN/ATSTTheStreet 0.00N/AN/AN/AXARSPDR S&P Aerospace & Defense ETF 2.68Moderate Buy$214.28N/ACurrent Analyst Ratings BreakdownLatest NXQ, CNC, XAR, and TST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/29/2025CNCCenteneJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$48.00 ➝ $30.007/28/2025CNCCenteneCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$65.00 ➝ $38.007/28/2025CNCCenteneUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$45.00 ➝ $31.007/28/2025CNCCenteneTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$42.00 ➝ $35.007/28/2025CNCCenteneOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$51.00 ➝ $43.007/25/2025CNCCenteneRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$68.00 ➝ $28.007/23/2025CNCCenteneWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$72.00 ➝ $30.007/21/2025CNCCenteneTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$73.00 ➝ $33.007/16/2025CNCCenteneTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$84.00 ➝ $42.007/16/2025CNCCenteneBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeNeutral ➝ Underperform$52.00 ➝ $30.00(Data available from 8/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCNCCentene$163.07B0.08$9.89 per share2.62$52.49 per share0.49NXQNuveen Select Tax-Free Income Portfolio 2N/AN/AN/AN/AN/AN/ATSTTheStreet$53.09M0.65$4.88 per share1.32$11.20 per share0.58XARSPDR S&P Aerospace & Defense ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCNCCentene$3.31B$4.046.423.521.071.15%9.57%3.10%N/ANXQNuveen Select Tax-Free Income Portfolio 2N/AN/A0.00∞N/AN/AN/AN/AN/ATSTTheStreet$18.22M-$0.60N/A∞N/A143.87%-2.15%-1.54%N/AXARSPDR S&P Aerospace & Defense ETFN/AN/A35.83∞N/AN/AN/AN/AN/ALatest NXQ, CNC, XAR, and TST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/25/2025Q2 2025CNCCentene$0.23-$0.16-$0.39-$0.51$44.71 billion$48.74 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCNCCenteneN/AN/AN/AN/AN/ANXQNuveen Select Tax-Free Income Portfolio 2$0.563.72%N/AN/AN/ATSTTheStreet$1.0015.53%N/AN/A N/AXARSPDR S&P Aerospace & Defense ETF$1.090.51%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCNCCentene0.641.101.10NXQNuveen Select Tax-Free Income Portfolio 2N/AN/AN/ATSTTheStreet0.016.236.23XARSPDR S&P Aerospace & Defense ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCNCCentene93.63%NXQNuveen Select Tax-Free Income Portfolio 213.25%TSTTheStreetN/AXARSPDR S&P Aerospace & Defense ETFN/AInsider OwnershipCompanyInsider OwnershipCNCCentene0.36%NXQNuveen Select Tax-Free Income Portfolio 21.00%TSTTheStreet30.00%XARSPDR S&P Aerospace & Defense ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCNCCentene60,500491.13 million489.37 millionOptionableNXQNuveen Select Tax-Free Income Portfolio 2N/A17.71 million17.54 millionNot OptionableTSTTheStreet5565.34 millionN/ANot OptionableXARSPDR S&P Aerospace & Defense ETFN/A17.68 millionN/ANot OptionableNXQ, CNC, XAR, and TST HeadlinesRecent News About These CompaniesETFs in Focus in Light of Aerospace & Defense Q2 Earnings BoostJuly 29, 2025 | zacks.comIs SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now?July 17, 2025 | zacks.comAerospace & Defense ETF (XAR) Hits New 52-Week HighJuly 17, 2025 | zacks.comSpace ETFs vs. Aerospace & Defense ETFs: View From AboveJuly 10, 2025 | etftrends.comEXAR: New Trends In The Aerospace And Defense Industry Drive This ETFJuly 3, 2025 | seekingalpha.comIran Escalation Could Rally U.S. Defense Stocks -- XAR My Top ETF ChoiceJune 24, 2025 | seekingalpha.comSPDR S&P Aerospace & Defense ETF declares quarterly distribution of $0.1320June 24, 2025 | msn.comShould You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?June 11, 2025 | zacks.comGuide to Aerospace & Defense ETFsJune 5, 2025 | zacks.comThe only S&P sector at new highs is still a Buy - SocGenMay 20, 2025 | msn.comIs SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now?May 15, 2025 | zacks.comAerospace & Defense ETFs at a One-Year High: Here's WhyMay 13, 2025 | zacks.comXAR: Often The Best Offense Is A Great Defense (And Aerospace) ETFMay 11, 2025 | seekingalpha.comThe Zacks Analyst Blog Highlights SMHX, XAR, AIVC, DAT and DRUPMay 9, 2025 | finance.yahoo.com5 Top-Ranked ETFs That Have Outperformed S&P 500 Since April LowMay 8, 2025 | zacks.comForget 'Sell in May': 5 Factors Why Wall Street ETFs Could Rally AheadMay 5, 2025 | zacks.comXAR Makes Notable Cross Below Critical Moving AverageApril 23, 2025 | nasdaq.comShould You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?April 8, 2025 | zacks.comNotable Two Hundred Day Moving Average Cross - XARApril 2, 2025 | nasdaq.comNotable ETF Inflow Detected - XAR, HWM, TDG, HIIMarch 27, 2025 | nasdaq.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Super Micro Computer Sees Unusual Volume—Catalyst Ahead?By Gabriel Osorio-Mazilli | July 25, 2025View Super Micro Computer Sees Unusual Volume—Catalyst Ahead?Why Centene Stock Dropped 40% — And Whether It's a Buy NowBy Leo Miller | July 8, 2025View Why Centene Stock Dropped 40% — And Whether It's a Buy NowNXQ, CNC, XAR, and TST Company DescriptionsCentene NYSE:CNC$25.92 -0.15 (-0.58%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$25.89 -0.03 (-0.12%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Nuveen Select Tax-Free Income Portfolio 2 NYSE:NXQNuveen Select Tax-Free Income Portfolio 2 is a closed-end investment fund/investment trust. Its investment objective is current income exempt from regular federal income tax, consistent with preservation of capital. The company was founded on May 21, 1992 and is headquartered in Chicago, IL.TheStreet NASDAQ:TSTTheStreet, Inc., a financial news and information provider, provides business to business (B2B) and business to consumer (B2C) content and products worldwide. The company operates through three segments: TheDeal/BoardEx, RateWatch, and Business to Consumer. Its B2B products include The Deal, a digital subscription model that delivers coverage primarily to institutional investors on changes in corporate control comprising merges and acquisitions, private equity, corporate activism, and restructuring; and BoardEx, an institutional relationship capital management database and platform, which holds profiles of approximately 1 million business leaders. The company's B2B products also consist of RateWatch, which publishes bank rate market information, such as competitive deposit, loan, and fee rate data for financial institutions, government agencies, academic researchers, banks, credit unions, and other commercial organizations. Its RateWatch product also offers banking-related product and fee comparisons, financial strength reporting, educational Webinars, mystery shopping, and consumer and financial institution surveys. The company's B2C products comprise TheStreet.com, an advertising-supported digital platform that provides business news and market analysis to individual investors; RealMoney and RealMoney Pro, which offer market commentary and analysis for active market participants and self-directed investors; and Action Alerts PLUS that teaches consumers on how to manage money for long term. TheStreet, Inc. was founded in 1996 and is headquartered in New York, New York.SPDR S&P Aerospace & Defense ETF NYSEARCA:XAR$214.28 -2.26 (-1.04%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$213.64 -0.63 (-0.30%) As of 08/1/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The SPDR S&P Aerospace & Defense ETF (XAR) is an exchange-traded fund that mostly invests in industrials equity. The fund tracks an equal-weighted index of US aerospace & defense companies. XAR was launched on Sep 28, 2011 and is managed by State Street. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
